Treatment of FeLV-induced immunodeficiency syndrome (FeLV-FAIDS) with controlled release capsular implantation of 2',3'-dideoxycytidine. [electronic resource]
Producer: 19890714Description: 147-60 p. digitalISSN:- 0166-3542
- Acquired Immunodeficiency Syndrome -- drug therapy
- Animals
- Antibodies, Monoclonal -- immunology
- Capsules
- Cats
- Dideoxynucleosides -- administration & dosage
- Disease Models, Animal
- Drug Implants
- Drug Therapy, Combination
- Gene Products, gag
- Immunologic Deficiency Syndromes -- drug therapy
- Infusions, Intravenous
- Injections, Subcutaneous
- Interferon Type I -- administration & dosage
- Leukemia Virus, Feline -- drug effects
- Retroviridae Proteins -- analysis
- Tetrahydrouridine -- pharmacology
- Tumor Necrosis Factor-alpha -- administration & dosage
- Virus Replication -- drug effects
- Zalcitabine -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.